首页 | 本学科首页   官方微博 | 高级检索  
     

药品不良反应监测的定义和范畴研究
引用本文:王大猷. 药品不良反应监测的定义和范畴研究[J]. 中国药物警戒, 2014, 0(12): 732-738
作者姓名:王大猷
作者单位:复旦大学附属华山医院,上海200040
摘    要:目的明确"药品不良反应监测"的定义及范畴,厘清药品不良反应监测的概念。方法回顾"监测"的语源学,以及作为术语在疾病监测或公共卫生监测中的定义和范畴;回顾药品不良反应监测的历史与实践,以及信息技术发展对其的影响;分析"药品不良反应监测"、"药物警戒"与"药物流行病学"的概念框架。结果"监测"的目标是有危害可能的趋向。"持续"、"系统"、"收集"、"分析"、"解释"、"传播"是术语"监测"的基本元素。药品不良反应监测从药物获批上市即开始,收集的数据不仅涉及药物的性质,还涉及药品标准、药品生产、药品储存和药品使用。信息技术极大地推动了药品不良反应监测。结论建议定义药品不良反应监测为:一项以药品不良反应为目标的公共卫生项目,由一整套持续、系统性地收集、归整、分析和阐释药品对人体的危害方面的数据(包括相关的志愿报告、电子医疗记录和实验室记录等)并及时向所有应该知道的人(监管部门、医务人员或/和公众)反馈的过程组成。目的是认识药品安全问题的分布特征和变化趋势,鉴别、评价、认识和交流药品非预期的有害作用,进一步认识药品的获益-风险的属性,防范或使药品的有害作用最小化。

关 键 词:药品不良反应  药品不良反应监测  药物警戒  药物流行病学

Srudy on Definition and Scope of Adverse Drug Reaction Surveillance
WANG Da-you. Srudy on Definition and Scope of Adverse Drug Reaction Surveillance[J]. Chinese JOurnal of Pharmacovigilance, 2014, 0(12): 732-738
Authors:WANG Da-you
Affiliation:WANG Da-you (Hua Shan Hospital, Fudan University, Shanghai 200040, China)
Abstract:Objective To clarify the definition and scope of adverse drug reaction surveillance". Methods The etymology usages, and previous defirfifions of'surveillance" were examined. The history and practice of adverse drug reaction surveillance was reviewed and a distinction among the concept framework of"adverse drug reaction surveiUance","pharmacovigilance" and "pharmacoepidemiology" was made. Results The targets of surveillance are harmful potentially; "ongoing", "systematic", "collection", "analysis", "interpretation", and "dissemination" have been seen in any surveillance program. Surveillance starts as soon as the drug is first approved or at any time thereafter. The collected data involves not only the safety problems caused by the nature of the drug, but also related to drug standards, pharmaceutical production, drug storage and drug usages. Information technology has greatly promoted the surveillance. Conclusion Definition of adverse drug reaction surveillance is proposed: A public health program aimed to adverse drug reactions, consisting of a set of processes for the ongoing systematic collection, compilation, analysis, interpretation of drug safety data(including relevant spontaneous reports, electronic health records, and experimental data), closely integrated with the timely and coherent dissemination of the results and assessment to those (including regulators, healthcare professionals and public) who have the right to know so that action can be taken. The purpose is to learn the distribution and trend of drug safety, to identify, evaluate, understand, and communicate the unexpected adverse drug effects, to perfect the drug benefit -risk profile, in order to prevent or mitigate the harmful effects of drugs.
Keywords:adverse drug reaction  adverse drug reaction surveillance  pharmacovigilance  pharmacoepidemiology
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号